Previous close | 1.1200 |
Open | 0.9000 |
Bid | 0.9500 |
Ask | 1.1000 |
Strike | 41.00 |
Expiry date | 2024-05-10 |
Day's range | 0.9000 - 0.9500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Besides Wall Street's top -and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures and a more stable supply chain.
ResMed (RMD) delivered earnings and revenue surprises of 10.94% and 1.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?